UroFill® Team Highlights Key Insights from 2024 AUA Annual Meeting

The 2024 Annual Meeting of the American Urological Association (AUA) in San Antonio, Texas, was an electrifying weekend for the UroFill® team. As the world’s largest gathering of urologists, the event provided an invaluable platform for sharing the latest research and breakthroughs in the field of urology.

Over four days, colleagues from across the globe convened to exchange insights and knowledge that can benefit patients worldwide. The meeting commenced with the Sexual Medicine Society of North America (SMSNA) hosting their societal meeting, featuring Dr. Landon Trost, who presented their positional statement on penile augmentation.

The SMSNA’s stance on hyaluronic injections for male enhancement emphasized the procedure’s established safety profile, with UroFill® serving as a prime example of a viable option for penile enhancement. However, the society strongly cautioned against the use of permanent fillers like paraffin and silicone, citing significant risks.

At UroFill®, we wholeheartedly support the SMSNA’s position against permanent fillers, aligning with our commitment to providing patients with safe and effective procedures. By advocating for responsible practices and discouraging amateurs and charlatans, we prioritize the well-being and satisfaction of our patients.

The insights shared at the AUA Annual Meeting underscore the importance of evidence-based approaches and informed decision-making in urological care. As we continue to advance in the field of penile enhancement, we remain dedicated to upholding the highest standards of safety, efficacy, and patient satisfaction.